Sharon Mates - Jan 4, 2016 Form 4/A - Amendment Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Chairman, President & CEO, Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Jan 4, 2016
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/7/2023, 06:08 PM
Date Of Original Report
Jan 6, 2016
Next filing
Aug 24, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Award $0 +86K $0.00 86K Jan 4, 2016 Common Stock 86K $53.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option vests as to one third of the shares on January 4, 2017, one third of the shares on January 4, 2018 and one third of the shares on January 4, 2019.

Remarks:

This Form 4/A is being filed solely to correct an error in the number of shares underlying the stock option granted on January 4, 2016.